ACELYRIN, INC. Common Stock (SLRN) Insider Trading
- $23,698,008.00
- $198,554.77
- July 17, 2024
- Shao-Lee Lin
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| July 17, 2024 | Director | 1 | $6.86 | Sell | $6.86 | |
| Feb. 20, 2024 | CEO | 15,701 | $7.60 | Sell | $119,327.60 | |
| Jan. 2, 2024 | CEO | 10,691 | $7.41 | Sell | $79,220.31 | |
| May 9, 2023 | CFO | 5,556 | $18.00 | Buy | $100,008.00 | |
| May 9, 2023 | Insider | 1,000 | $18.00 | Buy | $18,000.00 | |
| May 9, 2023 | Major Shareholder | 1,250,000 | $18.00 | Buy | $22,500,000.00 | |
| May 9, 2023 | Director | 60,000 | $18.00 | Buy | $1,080,000.00 |
Insiders are both buying and selling ACELYRIN, INC. Common Stock stock.
The insider traders at ACELYRIN, INC. Common Stock are: Shao-Lee Lin, Beth C Seidenberg, Biopartners Fund Ii Westlake, Daniel J Becker, Mardi Dier, and Ronald Oyston
The most active insider trader at ACELYRIN, INC. Common Stock is Shao-Lee Lin with 2 trades.
Shao-Lee Lin has sold the most ACELYRIN, INC. Common Stock stock with a total value of $317,875.51.
Biopartners Fund Ii Westlake has bought the most ACELYRIN, INC. Common Stock stock with a total value of $45,000,000.00.
The most recent insider trade for ACELYRIN, INC. Common Stock was on July 17, 2024.
The single biggest insider buy for ACELYRIN, INC. Common Stock was from Biopartners Fund Ii Westlake with a total value of $22,500,000.00 on May 9, 2023.
The single biggest insider sell for ACELYRIN, INC. Common Stock was from Shao-Lee Lin with a total value of $119,327.60 on Feb. 20, 2024.